These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20627976)

  • 1. An alternative to the war on drugs.
    Rolles S
    BMJ; 2010 Jul; 341():c3360. PubMed ID: 20627976
    [No Abstract]   [Full Text] [Related]  

  • 2. Coke and smack at the drugstore: harm reductive drug legalization: an alternative to a criminalization society.
    Mamber N
    Cornell J Law Public Policy; 2006; 15(3):619-64. PubMed ID: 17593583
    [No Abstract]   [Full Text] [Related]  

  • 3. Dutch drug policy: a model for America?
    Duncan DF; Nicholson T
    J Health Soc Policy; 1997; 8(3):1-15. PubMed ID: 10172982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supply reduction's hidden casualties: a view from the trenches.
    Strathdee SA; Patterson TL
    Addiction; 2009 Mar; 104(3):340-1; discussion 345-6. PubMed ID: 19207337
    [No Abstract]   [Full Text] [Related]  

  • 5. War on drugs. Is drugs policy the great game?
    Orrell JM
    BMJ; 2010 Aug; 341():c4610. PubMed ID: 20736279
    [No Abstract]   [Full Text] [Related]  

  • 6. Children and drug law reform.
    Cardoso FH
    Int J Drug Policy; 2012 Jan; 23(1):1-2. PubMed ID: 22071021
    [No Abstract]   [Full Text] [Related]  

  • 7. Still a war worth fighting. New anti-drug policy is right to focus on the public-health issue, but..
    May D
    Mod Healthc; 2010 May; 40(21):20. PubMed ID: 20540211
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimal timing of use reduction vs. harm reduction in a drug epidemic model.
    Caulkins JP; Tragler G; Wallner D
    Int J Drug Policy; 2009 Nov; 20(6):480-7. PubMed ID: 19361975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quagmire for our time: the war on drugs.
    Schrag P
    J Public Health Policy; 2002; 23(3):286-98. PubMed ID: 12325286
    [No Abstract]   [Full Text] [Related]  

  • 10. Harm reduction in Tanzania: an urgent need for multisectoral intervention.
    McCurdy S; Kilonzo GP; Williams M; Kaaya S
    Int J Drug Policy; 2007 May; 18(3):155-9. PubMed ID: 17689361
    [No Abstract]   [Full Text] [Related]  

  • 11. A resounding success or a disastrous failure: re-examining the interpretation of evidence on the Portuguese decriminalisation of illicit drugs.
    Hughes CE; Stevens A
    Drug Alcohol Rev; 2012 Jan; 31(1):101-13. PubMed ID: 22212070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing drug-related harm: Australia leads the way.
    Caldicott DG; Duff C
    Med J Aust; 2005 Feb; 182(3):140; author reply 141. PubMed ID: 15698366
    [No Abstract]   [Full Text] [Related]  

  • 13. The size and mix of government spending on illicit drug policy in Australia.
    Moore TJ
    Drug Alcohol Rev; 2008 Jul; 27(4):404-13. PubMed ID: 18584391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why Britain's drug czar mustn't wage war on drugs.
    Strang J; Clee WB; Gruer L; Raistrick D
    BMJ; 1997 Aug; 315(7104):325-6. PubMed ID: 9270445
    [No Abstract]   [Full Text] [Related]  

  • 15. [War on Drugs or War against Health? The pitfalls for public health of Puerto Rican drug policy].
    Santiago-Negrón S; Albizu-García CE
    P R Health Sci J; 2003 Mar; 22(1):49-59. PubMed ID: 12733445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative strategies.
    Jones RT
    Ciba Found Symp; 1992; 166():224-32; discussion 232-41. PubMed ID: 1638916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BZP-party pills: a review of research on benzylpiperazine as a recreational drug.
    Cohen BM; Butler R
    Int J Drug Policy; 2011 Mar; 22(2):95-101. PubMed ID: 21242080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The war on drugs.
    Barrie JR
    Bull Am Coll Surg; 2002 Jan; 87(1):57-8. PubMed ID: 17387836
    [No Abstract]   [Full Text] [Related]  

  • 19. Policy makers face a growing range of illicit drugs and aggressive marketing.
    Watson R
    BMJ; 2009 Nov; 339():b4676. PubMed ID: 19906754
    [No Abstract]   [Full Text] [Related]  

  • 20. Australian governments' spending on preventing and responding to drug abuse should target the main sources of drug-related harm and the most cost-effective interventions.
    McDonald D
    Drug Alcohol Rev; 2011 Jan; 30(1):96-100. PubMed ID: 21219503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.